Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9

Lidegaard, O., Nielsen, L. H., Skovlund, C. W., Skjeldestad, F. E., Lokkegaard, E.·2011·BMJ
DOI 10.1136/bmj.d6423

Cited by (607)

Items 301–400 of 607

  1. Safety, influence on the endometrium, sonographic changes and bleeding profile after 13 cycles with the new drospirenone only pill (DOP) for contraception
    Pedro‐Antonio Regidor, Enrico Colli, Dimitar Georgiev, Rossen Koytchev, Wolfram Richter · 2020 · Hormone Molecular Biology and Clinical Investigation
  2. A current perspective into young female sex hormone replacement: a review
    Giordano Imbroll, Miriam, Gruppetta, Mark · 2020 · Expert Review of Endocrinology & Metabolism
  3. Trends in the use of hormonal contraception in Estonia 2005–2019 and the risk of arterial and venous thromboembolism: a population-based study
    Katrin Kurvits, Ott Laius, Maia Uusküla, Made Laanpere · 2021 · The European Journal of Contraception & Reproductive Health Care
  4. The effect of combined oral contraceptives on thrombin generation assessed on ST Genesia– a paired clinical study
    Jesper Strandberg, Inger Lise Gade, Jette Nybo, Janus Laust Thomsen, Søren Risom Kristensen · 2025 · Thrombosis Journal
  5. Risques cardiovasculaires de la contraception orale estro-progestative : au-delà de la polémique…
    Héloïse Gronier, Geoffroy Robin · 2014 · Gynécologie Obstétrique & Fertilité
  6. Drospirenone detected in postmortem blood of a young woman with pulmonary thromboembolism: A case report and review of the literature
    Nozomi Idota, Masaki Kobayashi, Daisuke Miyamori, Yasuhiro Kakiuchi, Hiroshi Ikegaya · 2014 · Legal Medicine
  7. Is lipid profile determination necessary in women wishing to use oral contraceptives?
    Rogério Bonassi Machado, Carine Rejane Bernardes, Isadora Matias de Souza, Narayana Santana, Mariana Morimoto · 2012 · Contraception
  8. Combined hormonal contraceptives and the risk of venous and arterial thromboembolism and cardiovascular death: misuse of automated databases
    Samuel Shapiro · 2013 · Journal of Family Planning and Reproductive Health Care
  9. Combined oral contraceptives do not influence von Willebrand factor related biomarkers despite an induced acute phase response
    Julie Brogaard Larsen, Mustafa Vakur Bor, Anne‐Mette Hvas · 2014 · Thrombosis Research
  10. Thrombotic risk minimization for D iane‐35 and generics
    Irene D. Bezemer, Elisabeth Smits, Fernie J. A. Penning‐van Beest, Alex Asiimwe, Ron M. C. Herings · 2017 · Pharmacoepidemiology and Drug Safety
  11. Contraception de l’adolescente. RPC Contraception CNGOF
    Catherine Pienkowski, Audrey Cartault · 2018 · Gynécologie Obstétrique Fertilité & Sénologie
  12. A multicenter, randomized, placebo-controlled, double-blind, comparative study of dienogest at 1 mg/day in patients with primary and secondary dysmenorrhea
    Yutaka Osuga, Kôichi Hayashi, Shingo Kanda · 2020 · Fertility and Sterility
  13. Long-term safety of extended levonorgestrel-containing oral contraceptives in the United States
    Sigal Kaplan, Monica L. Bertoia, Florence T. Wang, Li Zhou, Amir Lass, Alison Evans, Sandeep Dhanda, Debabrata Roy, John D. Seeger · 2021 · Contraception
  14. Hormonal Contraceptive Use Among Women of Older Reproductive Age: Considering Risks and Benefits
    Naomi K. Tepper, Emily M. Godfrey, Suzanne G. Folger, Maura K. Whiteman, Polly A. Marchbanks, Kathryn M. Curtis · 2018 · Journal of Women s Health
  15. The progestogen content of combined oral contraceptives and venous thromboembolic risk
    Philip C Hannaford · 2011 · BMJ
  16. From Pulmonary Embolism to Chronic Thromboembolic Pulmonary Hypertension: A Pathophysiological Approach
    Parham Shahidi, Luise Mentzel, Stephan Blazek, Dmitriy S. Sulimov, Hölger Thiele, Karl Fengler · 2024 · Reviews in Cardiovascular Medicine
  17. Cost-effective screening strategy to prevent venous thromboembolism in combined oral contraceptive users
    Jonathan Douxfils · 2025 · Frontiers in Endocrinology
  18. Predicting venous thromboembolism risk from endogenous thrombin potential-based normalized activated protein C sensitivity ratio assay: toward early assessment of combined oral contraceptives
    Laure Morimont, Mitchell D. Creinin, ULYSSE J. GASPARD, Jean‐Michel Foidart, Jonathan Douxfils · 2025 · Research and Practice in Thrombosis and Haemostasis
  19. The relationship between cardiometabolic index and infertility in American adults: a population-based study
    Huifang Cheng, Xiaoli He, Xiaoke Jin · 2024 · Frontiers in Endocrinology
  20. Hormonal Contraception and Retinal Vascular Occlusion Risk
    Siar Niazi, Filip Gnesin, Baker Nawfal Jawad, Zia Niazi, Ellen Løkkegaard, Lina Steinrud Mørch, Christian Tobias Torp-Pedersen, Yousif Subhi, Amani Meaidi · 2025 · American Journal of Ophthalmology
  21. Efficacy and safety of a 21/7-active combined oral contraceptive with continuous low-dose ethinyl estradiol
    Robin Kroll, Ronald T. Ackerman, Robert Feldman, Brandon K. Howard, Herman Weiss, Jennifer Hsieh, Nancy A. Ricciotti · 2015 · Contraception
  22. Contraception des femmes en périménopause : place des spermicides
    D. Serfaty · 2017 · Journal of Gynecology Obstetrics and Human Reproduction
  23. A systematic review of cost-effectiveness analysis of screening interventions for assessing the risk of venous thromboembolism in women considering combined oral contraceptives
    Zanfina Ademi, C. Simone Sutherland, Joris van Stiphout, Jöelle Michaud, Goranka Tanačković, Matthias M. Schwenkglenks · 2017 · Journal of Thrombosis and Thrombolysis
  24. Thrombophilia
    Jason A. Freed, Kenneth Alan Bauer · 2019 · Elsevier eBooks
  25. Comparison of the pharmacologic and clinical profiles of new combined oral contraceptives containing estradiol
    Jeffrey T. Jensen, Johannes Bitzer, Marco Serrani · 2013 · Open Access Journal of Contraception
  26. A primer on the hormone-free interval for combined oral contraceptives
    Brian Hauck, Vivien Brown · 2015 · Current Medical Research and Opinion
  27. Comparison of the hemostatic effects of a levonorgestrel-releasing intrauterine system and leuprolide acetate in women with endometriosis: A randomized clinical trial
    Erciliene M.M. Yamaguti, Milena Bastos Brito, Rui Alberto Ferriani, Andrea Aparecida Garcia, Júlio César Rosa e Silva, Carolina Sales Vieira · 2014 · Thrombosis Research
  28. Profil des effets indésirables de l’implant d’étonogestrel (Nexplanon®, Implanon®) déclarés en France
    Corinne Simon, M.‐S. Agier, Johana Béné, Clotilde Muller, Laura Vrignaud, Henri Marret, A.‐P. Jonville‐Béra · 2016 · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction
  29. Contraception and Venous Thromboembolism: Risk Factors and Clinical Considerations
    Ashley Waddington, Carrie Ferguson, Robert L. Reid · 2016 · Open Journal of Obstetrics and Gynecology
  30. Impact of the 2013 French Pill Crisis on Women’s Behaviour Regarding Contraception
    Magali Lemaître, Glenn Lastennet, David Syr, Joseph Emmerich, Mahmoud Zureik · 2015 · Drugs - Real World Outcomes
  31. La contraception après 40 ans. RPC Contraception CNGOF
    M. Lambert, Emmanuelle Begon, Claude Hocké · 2018 · Gynécologie Obstétrique Fertilité & Sénologie
  32. Abnormal Uterine Bleeding
    Yochay Bar-Shavit, Jaron Rabinovici, Howard Carp · 2015 · Springer eBooks
  33. Ethinyl estradiol and levonorgestrel in a transdermal contraceptive delivery system
    Intira Sriprasert, Frank Z. Stanczyk, David F. Archer · 2015 · Expert Opinion on Pharmacotherapy
  34. Levonorgestrel correlates with less weight gain than other progestins during hormonal replacement therapy in Turner syndrome patients
    Mathez, Andréia Latanza Gomes, Monteagudo, Patrícia Teófilo, do Nascimento Verreschi, Ieda Therezinha, Dias-da-Silva, Magnus Régios · 2020 · Scientific Reports
  35. Combined Oral Contraceptives for Polycystic Ovary Syndrome: Pro and Contra (Review)
    И. А. Мазеркина, I. G. Davydov, Аляутдина Ольга Сергеевна · 2024 · Safety and Risk of Pharmacotherapy
  36. Hormone-related thrombosis: duration of anticoagulation, risk of recurrence, and the role of hypercoagulability testing
    Luuk J.J. Scheres, Saskia Middeldorp · 2024 · Hematology
  37. La balance bénéfices-risques des contraceptions hormonales estroprogestatives
    Geneviève Plu‐Bureau, Brigitte Raccah-Tebeka · 2022 · médecine/sciences
  38. Risque thrombotique des grossesses après un épisode de thrombose veineuse cérébrale
    O. Pourrât, J.-P. Neau, J F Pouget-Abadie, F. Pierre · 2013 · La Revue de Médecine Interne
  39. Contraception orale et risque vasculaire
    Philippe Bouchard, Alfred Spira, Yves G. Ville, J. Conard, Regine L. Sitruk-Ware · 2013 · Bulletin de l Académie Nationale de Médecine
  40. Preconception counseling of females with inflammatory bowel disease
    Amihai Rottenstreich, Ariella Bar‐Gil Shitrit · 2020 · Best Practice & Research Clinical Gastroenterology
  41. Combined hormonal contraceptive use in Europe before and after the European Commission mandated changes in product information
    Deeksha Khialani, Mary Elizabeth Jones, Szimonetta Komjáthiné Szépligeti, Anne Gulbech Ording, Véra Ehrenstein, Irene Petersen, Astrid van Hylckama Vlieg · 2020 · Contraception X
  42. "The Great Masquerader": An Interesting Case Series of Pulmonary Thromboembolism
    Sri Balaji Sritharan, C. Poornima Raj, Vidya TA, Narendhiran Pandurangan, Shinde Vikrant Vijaykumar · 2022 · Cureus
  43. Life-Threatening Complications of Hormonal Contraceptives: A Case History
    Saheed Khan, Yvo Michiel Smulders, Johanna I.P. de Vries, Angelique de Man · 2013 · Case Reports in Obstetrics and Gynecology
  44. Hemostatic effects of two desogestrel-containing combined oral contraceptive regimens: a multinational, multicenter, randomized, open-label study
    K. Peters, Nina Gordon, Nancy A. Ricciotti, Jennifer Hsieh, Brandon K. Howard, Herman Weiss · 2016 · Clinical and Experimental Obstetrics & Gynecology
  45. Acute pulmonary embolism after arthroscopic glenoid labral repair and subacromial decompression: case report and review of the literature
    Michelle Yagnatovsky, Amos Z. Dai, Michael A. Zacchilli, Laith M. Jazrawi · 2017 · The Physician and Sportsmedicine
  46. Severely biased review of studies assessing the risk of venous thrombosis in users of drospirenone‐containing oral contraceptives
    Øjvind Lidegaard · 2018 · BJOG An International Journal of Obstetrics & Gynaecology
  47. Risks of venous thromboembolic complications in related to combined oral contraceptives
    Karina A. Gabelova, N. A. Shabanova, V. F. Bezhenar, Edwin E. Zvartau, Yu. A. Akishina · 2022 · Obstetrics Gynecology and Reproduction
  48. Do Norwegian providers comply with national recommendations when prescribing combined oral contraceptives to starters? A cohort study
    Julie Ekman, Finn Egil Skjeldestad · 2019 · BMJ Open
  49. Abnormal Uterine Bleeding
    Eran Zilberberg, Howard Carp · 2021 · Springer eBooks
  50. Fresh evidence confirms links between newer contraceptive pills and higher risk of venous thromboembolism
    Susan Sara Jick · 2015 · BMJ
  51. Addiction and Lesbian, Gay, Bisexual and Transgender (LGBT) Issues
    Lee, Steven Joseph · 2015 · Textbook of Addiction Treatment: International Perspectives
  52. COVID-19 infection increases the risk of venous thromboembolism during pregnancy and the postpartum period
    Anne K. Örtqvist, Jonas K. Söderling, Maria C. Magnus, Stine Kjær Urhøj, Siri E. Håberg, Olof Stephansson · 2025 · European Journal of Epidemiology
  53. Cancer Cell‐Derived Large Extracellular Vesicles Promote Venous Thromboembolism by Activating NETosis Through Delivering CYBA
    Xiangji Li, Yingjiao Ju, Chenjie Xu, Shixiang Ma, Sun Lan, Qingdong Guo, Mingyuan Liu, Yibin Xie, Li Min · 2025 · Advanced Science
  54. Web-Based Survey Piloting Process as a Model for Developing and Testing Past Contraceptive Use and Pregnancy History: Cystic Fibrosis Case Study
    Emily M. Godfrey, Malaika Schwartz, Karen Hinckley Stukovsky, Danielle Woodward, Amalia Magaret, Moira L. Aitken · 2023 · JMIR Formative Research
  55. Gestodene, a novel positive allosteric modulator of PAR1, enhances PAR1-mediated human platelet aggregation
    Sohyeon Park, Yunkyung Heo, Il Kwon, Sungwoo Jo, Hyejin Jeon, Yechan Lee, Jieun Kim, Ji Hoe Heo, Wan Namkung · 2024 · Frontiers in Pharmacology
  56. Approaching ovarian endometrioma with medical therapy
    M. Vignali, Eugenio SOLIMA, Valeria BARBERA, Chiara BECHERINI, Gaia M. BELLONI · 2021 · Minerva Obstetrics and Gynecology
  57. Progestogen-only oral contraceptives
    Rogério Bonassi Machado, Carlos Alberto Politano · 2022 · Revista Brasileira Ginecologia e Obstetrícia
  58. Consensus conference results on contraception in women beyond 40 years of age
    Angelo Cagnacci, Franca Fruzzetti, Vincenzina Bruni, Alessandro Gambera, Maurizio Guida, Gloria Bonaccorsi, Ambrogio Pietro Londero, for the Italian Society of Contraception (S.I.C.) · 2025 · The European Journal of Contraception & Reproductive Health Care
  59. Uterine Fibromyoma and Intravascular Thrombosis—Eight Cases
    Pratibha Devabhaktuni, Prem Chand Gupta, Somaraju Bhupatiraju, Balamba Puranam, Saleem M. Abdul · 2014 · Open Journal of Obstetrics and Gynecology
  60. Chronic thromboembolic pulmonary hypertension complicating long-term cyproterone acetate therapy
    David Montani, Laurent Bertoletti, Marie‐Camille Chaumais, Swanny Perrin, Dominique Fabre, Ari Chaouat, Xavier Jaïs, Gérald Simonneau, Marc J.C. Humbert · 2014 · European Respiratory Review
  61. Economic evaluation of a novel genetic screening test for risk of venous thromboembolism compared with standard of care in women considering combined hormonal contraception in Switzerland
    C. Simone Sutherland, Zanfina Ademi, Jöelle Michaud, Nadine Schur, Myriam Lingg, Arjun Bhadhuri, Thierry D. Pache, Johannes Bitzer, Pierre Suchon, Valerie Albert et al. · 2019 · BMJ Open
  62. Best Practice Contraception Care for Women with Obesity: A Review of Current Evidence
    Kathleen M McNamee, Alison B. Edelman, Raymond Li, Simranvir Kaur, Deborah J. Bateson · 2022 · Seminars in Reproductive Medicine
  63. Life-Threatening Contraceptive-Related Pulmonary Embolism in a 14-Year-Old Girl with Hereditary Thrombophilia
    Maja Hellfritzsch, Erik Lerkevang Grove · 2015 · American Journal of Case Reports
  64. Selection of Contraceptive Therapy for Patients with Thrombophilia: A Review of the Evidence
    Whitney D. Maxwell, Merna Jacob, Lisa Beth Spiryda, Charles L. Bennett · 2014 · Journal of Women s Health
  65. Developments in contraception
    Edith Weisberg · 2013 · Expert Opinion on Pharmacotherapy
  66. Consensus canadien sur la contraception (3e partie de 4) : chapitre 8 – contraception à progestatif seul
    Amanda Black, Édith Guilbert, Dustin Costescu, Sheila Dunn, William A. Fisher, Sari Leanne Kives, Melissa Mirosh, Wendy V. Norman, Helen C. Pymar, Robert L. Reid et al. · 2016 · Journal of Obstetrics and Gynaecology Canada
  67. Aspirin restores endothelial function by mitigating 17β-estradiol-induced α-SMA accumulation and autophagy inhibition via Vps15 scaffold regulation of Beclin-1 phosphorylation
    Hangyu Wu, Siyang Wu, Yingchao Zhu, Jiayi Cheng, Shazhou Ye, Yang Xi, Qin Huang, Yisheng Zhang, Shizhong Bu · 2020 · Life Sciences
  68. Hormonal contraception and venous thromboembolic risk in midlife women
    Øjvind Lidegaard · 2012 · Maturitas
  69. Cohort Profile: The Danish Venous Thromboembolism Cohort – A Linkage Between Danish National Health Surveys and Health Registers
    Erzsébet Horváth–Puhó, Lars Henning Pedersen, Søren Korsgaard Martiny, Lau Amdisen, Jakob Hansen Viuff, Ola Ekholm, Henrik Toft Sørensen · 2025 · Clinical Epidemiology
  70. Do combined oral contraceptives induce formation of tissue factor?
    Søren Risom Kristensen, Jette Nybo, Jesper Strandberg · 2025 · Research and Practice in Thrombosis and Haemostasis
  71. Venous thromboembolism in users of progestin-only hormonal contraception in Sweden: a prospective, register-based, nested, matched case–control study
    Anna L. Eriksson, Erik Östgärd Thunström, Jari Martikainen, Georgios Lappas, Annika Rosengren, Jenny M. Kindblom · 2026 · The Lancet Obstetrics Gynaecology & Women s Health
  72. A detailed review of pharmacokinetics/pharmacodynamics of progestogens in oral contraception
    ULYSSE J. GASPARD, Guillaume Chatel, Jonathan Douxfils, Frank Z. Stanczyk · 2026 · Frontiers in Endocrinology
  73. Contemporary menopausal hormone therapy and thrombotic disease: nationwide nested case-control study
    Julie Berggreen, Nelsan Pourhadi, Hannah Karin Wood-Kurland, Ellen Løkkegaard, Christian Tobias Torp-Pedersen, Amani Meaidi · 2026 · BMJ
  74. BRCA mutation carriers’ perception about benefits and risks associated with combined hormonal contraceptives use
    Giovanni Grandi, Francesca Monari, Valentina Boggio Sola, Laura Cortesi, Angela Toss, Maria Chiara Del Savio, Chiara Melotti, Maria Grazia Centurioni, Claudio Gustavino, Liliana Varesco et al. · 2022 · The European Journal of Contraception & Reproductive Health Care
  75. Effectiveness of osteopathic treatment in women with primary dysmenorrhea: A randomised controlled trial
    Maximilian Plathner, Lars Wolf · 2025 · Journal of Bodywork and Movement Therapies
  76. Oral Contraceptives Induce Time- and Intestinal Segment-Dependent Shifts in the Gut Microbiota
    Anna Clapp Organski, Anjali Reddivari, Lavanya Reddivari, Douglas K. Brubaker, Kelly N. Z. Fuller, John P. Thyfault, Tzu-Wen Cross · 2025 · Nutrients
  77. Contraceptive use in France in 2012 and 2022: a descriptive analysis of two repeated nationwide cross-sectional studies
    Lorraine Poncet, Noémie Roland, Romain FORTUNA, Karima Hider‐Mlynarz, Rosemary Dray‐Spira, Alain Weill, Mahmoud Zureik · 2025 · The Lancet Regional Health - Europe
  78. Expert opinion on a flexible extended regimen of drospirenone/ethinyl estradiol contraceptive
    Leo L. Han, Jeffrey T. Jensen · 2014 · Expert Opinion on Pharmacotherapy
  79. The polycystic ovary syndrome: a position statement from the European Society of
    Gerard S. Conway, Didier Dewailly, Evanthia Diamanti‐Kandarakis, Stephen Franks, Alessandra Gambineri, Fahrettin Keleştimur, Djuro Μacut, Dragan Micić, Renato Pasquali, Marija Pfeifer et al. · 2014
  80. Hormonal anticonception anno 2013: a clinician's view.
    Marc A. Dhont, V. Verhaeghe · 2013 · Europe PMC (PubMed Central)
  81. Does the type of progestin influence the production of clotting factors?
    Frank Z. Stanczyk, Brett W. Mathews, Victoria Kristence Cortessis · 2016 · Contraception
  82. Reduction in use of cyproterone/ethinylestradiol (Diane-35 and generics) after risk minimization measures in the Netherlands, UK and Italy
    Fernie J. A. Penning‐van Beest, Irene D. Bezemer, Elisabeth Smits, Luis Alberto García Rodríguez, Lucía Cea Soriano, Francesco Lapi, Monica Simonetti, Alex Asiimwe, Ron M. C. Herings · 2020 · Contraception
  83. Mechanical and Physical Behavior of Fibrin Clot Formation and Lysis in Combined Oral Contraceptive Users
    Albe C. Swanepoel, Janette Bester, Zelda de Lange · 2020 · Microscopy and Microanalysis
  84. Production and characterization of newly developed alcohol-free topical liposome-gel transdermal drug delivery systems containing estradiol (E2)/ estriol (E3) for post-menopausal women
    İsmail Aslan, Ali Fuat AYTEKİN · 2023 · Journal of Research in Pharmacy
  85. Venous thromboembolism among physically active young adult females
    Michael J. Shapiro, Eva N. Hamulyák, Avi Leader, Regev Landau, Saskia Middeldorp, Anna Gurevich‐Shapiro · 2023 · Research and Practice in Thrombosis and Haemostasis
  86. Out-of-hospital cardiac arrest associated with venous thromboembolism–a Swedish population-based cohort study
    Emma Bendz, Anna Oksanen, Susanna C. Larsson, Joel Ohm, Therese Djärv, Maria Bruzelius · 2024 · Journal of Thrombosis and Haemostasis
  87. Acute cerebrovascular incident in a young woman: Venous or arterial stroke? – Comparative analysis based on two case reports
    Katarzyna Sleiman, Anna Zimny, Edyta Kowalczyk, Marek J. Sąsiadek · 2013 · Polish Journal of Radiology
  88. Thrombophilie : quel bilan en 2012 ?
    Ph. de Moerloose, Alessandro Casini, Françoise Boehlen · 2012 · La Revue de Médecine Interne
  89. Combined oral contraceptives and risk of venous thromboembolism: there is higher risk in new generations compared to second generations, but paradoxically not in norgestimate-containing-pills
    Geneviève Plu‐Bureau · 2015 · BMJ Evidence-Based Medicine
  90. A Cross-Sectional Study of the Choice of Oral Estrogen Contraceptives in Women Seeking Contraceptive Counseling: What Type of Pill Do Women Prefer After Being Counseled?
    Inaki Lete Nagore Barbadillo, Lorea Ugarte · 2015 · Gynecology & Obstetrics
  91. Contraception
    Courtney A. Schreiber, Kurt Thomas Barnhart · 2013 · Elsevier eBooks
  92. Identify underlying cause of hirsutism and individualize treatment as required
    Adis Medical Writers · 2014 · Drugs & Therapy Perspectives
  93. Oral Contraceptives and the Risk of Venous Thromboembolism
    Susan Sara Jick · 2014 · Springer eBooks
  94. Suivi et prise en charge gynécologique chez les femmes atteintes de mucoviscidose
    Christine Rousset‐Jablonski, Quitterie Reynaud, Raphaële NOVE-JOSSERAND, Stéphane Durupt, I. Durieu · 2018 · Revue des Maladies Respiratoires
  95. Progestogens in Contraception
    Johannes Bitzer · 2015 · Springer eBooks
  96. Time trends in pulmonary embolism: A matter of age and gender
    Bengt Zöller · 2013 · Thrombosis Research
  97. Reproductive and Sexual Health of Individuals with Disabilities
    Brianna A. Marzolf, Maneesha Finkle, Laura Kruger, Sherri Eldin, Nafeeza Hussain · 2025 · Primary Care Clinics in Office Practice
  98. Safety and efficacy of hormonal therapies used to treat endometriosis in women suffering migraine
    Umberto Perrone, Fabio Barra, Giulio Evangelisti, Alberto Izzotti, Claudio Gustavino, Andrea Antonelli, Umberto Leone Roberti Maggiore, Simone Ferrero · 2026 · Expert Opinion on Drug Safety
  99. Thrombose et contraception estroprogestative : mise au point du groupe de travail pluridisciplinaire CNGOF-FNCGM-GEHT-SFMV
    Nathalie Chabbert‐Buffet, B. Guigues, Nathalie Trillot, C. Biron, Pierre‐Emmanuel Morange, Gilles Pernod, Michèle Scheffler, S. Brugere, Bernard Hedon · 2013 · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction
  100. Hirsutismus – Medikamentöse Therapie Gemeinsame Stellungnahme der Deutschen Gesellschaft für Gynäkologische Endokrinologie und Fortpflanzungsmedizin e.V. und des Berufsverbands der Frauenärzte e.V.
    T. Rabe, Christian Albring, Ulrike Blume‐Peytavi, Christian Egarter, F. Geisthövel, K. König, H. Kühl, E. Merkle, Mueck Ao, Nicole Reisch et al. · 2015 · Journal für Reproduktionsmedizin und Endokrinologie